Current Challenges and Opportunities in Treating GlioblastomaAndrea Shergalis, Nouri Neamati|Pharmacological Reviews|2018Cited by 888
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapyYonghyun Lee, James J. Moon, Cheng Xu et al.|Nature Communications|2023Cited by 84
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitorKavya Ramkumar, Nouri Neamati|Nature Communications|2016Cited by 74
Mechanisms underlying the cytotoxicity of a novel quinazolinedione‐based redox modulator, <scp>QD</scp>232, in pancreatic cancer cellsDivya Pathania, Nouri Neamati|British Journal of Pharmacology|2014Cited by 9